aspirin has been researched along with me 3277 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ikeda, Y; Kawano, K; Kondo, K; Umemura, K | 1 |
Fujishima, K; Ikeda, Y; Kawano, KI; Kondo, K; Umemura, K | 1 |
Hokamura, K; Ikeda, Y; Kawano, KI; Kondo, K; Suzuki, Y; Umemura, K | 1 |
3 other study(ies) available for aspirin and me 3277
Article | Year |
---|---|
Superiority of platelet integrin GPIIb-IIIa receptor antagonist over aspirin in preventing cyclic flow reductions in the guinea pig middle cerebral artery.
Topics: Amides; Animals; Aspirin; Brain; Cerebral Arteries; Cerebrovascular Circulation; Fibrinolytic Agents; Guinea Pigs; Male; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Regional Blood Flow; Thromboxane B2 | 1999 |
ME3277, a GPIIb/IIIa antagonist reduces cerebral infarction without enhancing intracranial hemorrhage in photothrombotic occlusion of rabbit middle cerebral artery.
Topics: Amides; Animals; Arterial Occlusive Diseases; Aspirin; Bleeding Time; Cerebrovascular Circulation; Fibrinolytic Agents; Infarction, Middle Cerebral Artery; Intracranial Hemorrhages; Intracranial Thrombosis; Male; Methacrylates; Neurologic Examination; Photochemistry; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Rabbits | 2000 |
Thromboxane A(2) synthase inhibitor enhanced antithrombotic efficacy of GPIIb-IIIa receptor antagonist without increasing bleeding.
Topics: Amides; Animals; Anticoagulants; Aspirin; Biphenyl Compounds; Bleeding Time; Blood Platelets; Drug Synergism; Fibrinolytic Agents; Guinea Pigs; Hemorrhage; Heparin; Heptanoic Acids; Hindlimb; Male; Methacrylates; Middle Cerebral Artery; Partial Thromboplastin Time; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thromboxane-A Synthase | 2001 |